e-learning
resources
Vienna 2012
Monday, 03.09.2012
Sleep disorders in internal medicine
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
In sleep apnea patients nonalcoholic fatty liver disease (NAFLD) is associated with the severity of intermittent hypoxia and more severe endothelial dysfunction
C. Minville, M.N. Hilleret, R. Tamisier, P. Levy, J.P. Zarski, J.L. Pepin (Quebec, Canada; Grenoble, France)
Source:
Annual Congress 2012 - Sleep disorders in internal medicine
Session:
Sleep disorders in internal medicine
Session type:
Poster Discussion
Number:
1882
Disease area:
Sleep and breathing disorders
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
C. Minville, M.N. Hilleret, R. Tamisier, P. Levy, J.P. Zarski, J.L. Pepin (Quebec, Canada; Grenoble, France). In sleep apnea patients nonalcoholic fatty liver disease (NAFLD) is associated with the severity of intermittent hypoxia and more severe endothelial dysfunction. Eur Respir J 2012; 40: Suppl. 56, 1882
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Optimizing invasive ventilation for SMA type 1 children who are receiving the gene therapy
Middle-long term pulmonary abnormalities after severe COVID-19 pneumonia which required invasive ventilation
Adherence predictors to positive airway pressure (PAP) treatment in patients with obstructive sleep apnea (OSA)
Related content which might interest you:
The impact of severe obstructive sleep apnea and obesity on nonalcoholic fatty liver disease.
Source: International Congress 2017 – Obstructive and central sleep apnoea: consequences and comorbidities
Year: 2017
Increased risk of obstructive sleep apnoea in patients with non-alcoholic fatty liver disease
Source: Annual Congress 2012 - Metabolic and cardiovascular consequences of OSA II
Year: 2012
Association between obstructive sleep apnea and the severity of non-alcoholic fatty liver disease.
Source: International Congress 2019 – Impact of sleep-disordered breathing in other diseases
Year: 2019
Association between obstructive sleep apnea and nonalcoholic fatty liver disease
Source: International Congress 2019 – Impact of sleep-disordered breathing in other diseases
Year: 2019
Increased liver stiffness in patients with severe sleep apnoea and metabolic comorbidities
Source: Eur Respir J, 51 (6) 1800601; 10.1183/13993003.00601-2018
Year: 2018
The impact of obstructive sleep apnoea syndrome on endothelial function in patients with moderate and severe hypertension
Source: Eur Respir J 2005; 26: Suppl. 49, 39s
Year: 2005
Relationship between OSA and non-alcoholic fatty liver disease
Source: ERS Conference
Year: 2015
Chronic intermittent hypoxia is a major trigger for non-alcoholic fatty liver disease
Source: Annual Congress 2011 - Physiology and cardiometabolic comorbidities in obstructive sleep apnoea
Year: 2011
Markers of liver dysfunction in patients with obstructive sleep apnea
Source: Annual Congress 2011 - Obstructive sleep apnoea: inflammation and metabolism
Year: 2011
Nonalcoholic fatty liver disease in chronic obstructive pulmonary disease
Source: Eur Respir J, 49 (6) 1601923; 10.1183/13993003.01923-2016
Year: 2017
Non-alcoholic fatty liver disease (NAFLD): A new mechanism for co-morbidities in chronic obstructive pulmonary disease (COPD)?
Source: International Congress 2016 – Recent high impact findings regarding COPD comorbidities
Year: 2016
Free fatty acids levels and the metabolic syndrome in patients with obstructive sleep apnea
Source: Annual Congress 2010 - Obesity: positive effects of bariatric surgery and exercise
Year: 2010
Association of vascular endothelial dysfunction with disease severity in obstructive sleep apnoea
Source: Annual Congress 2008 - Cardiovascular complications in obstructive sleep apnoea
Year: 2008
Nocturnal desaturation without obstructive sleep apnea (OSA) in patients with mild/moderate chronic obstructive pulmonary disease (COPD): a link with systemic inflammation (SI)?
Source: Annual Congress 2008 - Comorbidities in COPD
Year: 2008
Adipose tissue in obesity and obstructive sleep apnoea
Source: Eur Respir J 2012; 39: 746-767
Year: 2012
Is heart type fatty acid binding protein a marker of cardiac damage in patients with acute attacks of chronic obstructive pulmonary disease?
Source: Annual Congress 2008 - Structural remodelling in COPD
Year: 2008
Early peripheral muscle structural and metabolic impairment in chronic obstructive pulmonary disease (COPD) patients cannot be considered as a consequence of sedentarity
Source: Annual Congress 2011 - Skeletal muscle weakness in COPD: physical (in)activity and biological markers
Year: 2011
Significant associations between obstructive sleep apnea and fat accumulation in the liver in male subjects without visceral obesity
Source: Annual Congress 2013 –A metabolic medley: sleep disordered breathing
Year: 2013
Leukocytosis as a marker of chronic inflammation and early cardiovascular risk in patients with obstructive sleep apnea syndrome
Source: Eur Respir J 2007; 30: Suppl. 51, 593s
Year: 2007
High prevalence of obstructive sleep apnea syndrome in nondialyzed severe chronic renal failure patients
Source: Annual Congress 2009 - Socio-economic and epidemiological aspects of sleep apnoea
Year: 2009
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept